You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

pd-1

Showing 1 - 8 of 8
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hepatocellular Carcinoma Trial in Beijing (iNKT Cells, PD-1, Regorafenib)

Not yet recruiting
  • Hepatocellular Carcinoma
  • iNKT Cells
  • +2 more
  • Beijing, Beijing, China
    Beijing Youan Hospital,Capital Medical University
Jul 24, 2023

Rectal Cancer Trial (PD-1, SCRT, Bevacizumab)

Not yet recruiting
  • Rectal Cancer
  • PD-1
  • +5 more
  • (no location specified)
Dec 6, 2022

Advanced Malignant Solid Tumor Trial in Hangzhou (biological, other, drug, procedure)

Recruiting
  • Advanced Malignant Solid Tumor
  • iNeo-Vac-P01
  • +3 more
  • Hangzhou, Zhejiang, China
    Run Run Shaw Hospital Affiliated to Zhejiang University School o
Apr 25, 2021

Muscle Invasive Bladder Cancer Trial in Tianjin (pegylated liposomal doxorubicin (PLD), PD-1)

Unknown status
  • Muscle Invasive Bladder Cancer
  • pegylated liposomal doxorubicin (PLD)
  • PD-1
  • Tianjin, Tianjin, China
    Tianjin Medical Unversity Second Hospital
Sep 25, 2019

PD-1, Chemoradiotherapy, Gastroesophageal Junction Cancer Trial (PD-1)

Not yet recruiting
  • PD-1
  • +2 more
  • PD-1
  • (no location specified)
Aug 17, 2019

Advanced Liver Cancer Trial in Nanning (PD-1, Sorafenib)

Unknown status
  • Advanced Liver Cancer
  • Nanning, Guangxi, China
    TaoBai
Nov 13, 2019

Hepatocellular Carcinoma

Unknown status
  • HepatoCellular Carcinoma
  • Nanning, Guangxi, China
    TaoBai
Nov 3, 2019

Head and Neck Squamous Cell Carcinoma Trial in Nanning (PD-1)

Unknown status
  • Head and Neck Squamous Cell Carcinoma
  • PD-1
  • Nanning, Guangxi, China
    Guangxi Medical University Affiliated Tumour Hospital
Dec 10, 2019